Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Scientific Reports|February 23, 2022
CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme functionKatalin Mangó, Ádám Ferenc Kiss, Ferenc Fekete, et al.
FEBS Letters|December 29, 2004
The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytesKatalin Monostory, Krisztina Kohalmy, Russell A Prough, et al.
Orvosi Hetilap|June 27, 2008
[Crosstalk between cholesterol homeostasis and drug metabolism]Krisztina Kohalmy, Damjana Rozman, Jean-Marc Pascussi, et al.
Computers in Biology and Medicine|April 10, 2013
An algorithm for rapid computational construction of metabolic networks: a cholesterol biosynthesis exampleAleš Belič, Denis Pompon, Katalin Monostory, et al.
Scientific Reports|August 25, 2021
Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjectsFerenc Fekete, Katalin Mangó, Máté Déri, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 21, 2012
Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expressionManna Temesvári, László Kóbori, József Paulik, et al.
Polish Journal of Pharmacology|March 30, 2004
In vitro induction of cytochrome P450 enzymes in hepatocytes isolated from the regenerating rat liverViola Tamási, Zsuzsanna Riedl, Ottó Dobozy, et al.
Pharmacological Reports : PR|April 18, 2018
Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype predictionÁdám Ferenc Kiss, Dorottya Vaskó, Máté Tamás Déri, et al.
Pharmacological Reports : PR|February 13, 2009
Limited applicability of 7-methoxy-4-trifluoromethylcoumarin as a CYP2C9-selective substratePálma Porrogi, László Kóbori, Krisztina Kõhalmy, et al.
Epilepsy & Behavior Case Reports|November 7, 2015
Adverse events in a newborn on valproate therapy due to loss-of-function mutations in CYP2C9Andrea Nagy, Tamás Bűdi, Manna Temesvári, et al.
Pageof 8